Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximab

Trial Profile

Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximab

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jul 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
    • 07 Apr 2014 Planned initiation date changed from 1 Oct 2013 to 12 Dec 2013 as reported by University Hospital Medical Information Network - Japan.
    • 03 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top